{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:51:59Z","timestamp":1793479919831,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"\n Importance<\/jats:title>\n Large-scale evidence for the efficacy of continuation and maintenance electroconvulsive therapy (c\/mECT) is lacking.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To provide an exhaustive and naturalistic insight into the real-world outcomes and the cost-effectiveness of c\/mECT in a large dataset.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study included all patients in the Danish National Patient Registry who initiated treatment with ECT from 2003 through 2022. The data were analyzed from October 2023 to February 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n ECT. An algorithm to identify c\/mECTs in the dataset was developed: (&amp;gt;3 treatments with \u22657 and &amp;lt;90 days between adjacent treatments, occurring within a time frame of 180 days [cECT] or more [mECT] after an acute [aECT] series).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The association of c\/mECT with subsequent 6- to 12-month risk of hospitalization or suicidal behavior using Cox proportional hazard regression with multiple adjustments and aECT only as a reference, propensity score matching, and self-controlled case series analysis using a Poisson regression model. A cost-effectiveness analysis based on hospitalization and ECT expenses was made.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 19\u202f944 individuals were treated with ECT (12\u202f157 women [61%], 7787 men [39%]; median [IQR] age, 55 [41-70] years). Of these, 1533 individuals (7.7%) received c\/mECT at any time point (1017 [5.1%] cECT only and 516 [2.6%] mECT). Compared with patients receiving aECT only, c\/mECT patients more frequently experienced schizophrenia (odds ratio [OR], 2.14; 95% CI, 1.86-2.46) and schizoaffective disorder (OR, 2.42; 95% CI, 1.90-3.09) and less frequently unipolar depression (OR, 0.56; 95% CI, 0.51-0.62). In all models, c\/mECT was associated with a lower rate of hospitalization after finishing aECT (eg, 6-month adjusted hazard ratio, 0.68; 95% CI, 0.60-0.78 [Cox regression]; 6-month incidence rate ratio, 0.51; 95% CI, 0.41-0.62 [Poisson regression]). There was no significant difference in the risk of suicidal behavior. Compared with the periods before the end of aECT, c\/mECT was associated with a substantial reduction in total treatment costs.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In a nationwide and naturalistic setting, c\/mECT after aECT was infrequently used but associated with a lower risk of readmission than aECT alone. The totality of the evidence indicates that c\/mECT should be considered more often to prevent relapse after successful aECT in patients whose condition does not respond sufficiently to other interventions.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2024.2360","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T11:02:05Z","timestamp":1726657325000},"page":"1207","source":"Crossref","is-referenced-by-count":28,"title":["Clinical Outcomes of Continuation and Maintenance Electroconvulsive Therapy"],"prefix":"10.1001","volume":"81","author":[{"given":"Anders","family":"J\u00f8rgensen","sequence":"first","affiliation":[{"name":"Psychiatric Center Copenhagen, Frederiksberg, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikke Hoerdam","family":"Gronemann","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten P.","family":"Rozing","sequence":"additional","affiliation":[{"name":"Psychiatric Center Copenhagen, Frederiksberg, Copenhagen, Denmark"},{"name":"Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Psychiatric Center Copenhagen, Frederiksberg, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Osler","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg, Copenhagen, Denmark"},{"name":"Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"yoi240052r1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","article-title":"Electroconvulsive therapy.","volume":"386","author":"Espinoza","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"yoi240052r2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/YCT.0b013e31826ea8c4","article-title":"Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.","volume":"29","author":"Prudic","year":"2013","journal-title":"J ECT"},{"issue":"10","key":"yoi240052r3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jama.285.10.1299","article-title":"Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.","volume":"285","author":"Sackeim","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"yoi240052r4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT).","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"12","key":"yoi240052r5","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archpsyc.63.12.1337","article-title":"Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).","volume":"63","author":"Kellner","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"yoi240052r6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1176\/appi.ajp.2016.16010118","article-title":"A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study.","volume":"173","author":"Kellner","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"10","key":"yoi240052r7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/brainsci11101340","article-title":"Can the addition of maintenance electroconvulsive therapy to pharmacotherapy improve relapse prevention in severe major depressive disorder? a randomized controlled trial.","volume":"11","author":"Mart\u00ednez-Amor\u00f3s","year":"2021","journal-title":"Brain Sci"},{"issue":"5","key":"yoi240052r8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0004867417743343","article-title":"Electroconvulsive therapy in the continuation and maintenance treatment of depression: systematic review and meta-analyses.","volume":"52","author":"Elias","year":"2018","journal-title":"Aust N Z J Psychiatry"},{"key":"yoi240052r9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jad.2020.03.152","article-title":"Maintenance ECT is associated with sustained improvement in depression symptoms without adverse cognitive effects in a retrospective cohort of 100 patients each receiving 50 or more ECT treatments.","volume":"271","author":"Luccarelli","year":"2020","journal-title":"J Affect Disord"},{"issue":"3","key":"yoi240052r10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/YCT.0000000000000914","article-title":"The efficacy and tolerability of continuation and maintenance electroconvulsive therapy for depression: a systematic review of randomized and observational studies.","volume":"39","author":"Rowland","year":"2023","journal-title":"J ECT"},{"issue":"pt A","key":"yoi240052r11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jad.2021.10.052","article-title":"Evaluating maintenance electroconvulsive therapy in bipolar disorders: 3-year mirror-image study.","volume":"298","author":"Madero","year":"2022","journal-title":"J Affect Disord"},{"issue":"2","key":"yoi240052r12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/YCT.0000000000000628","article-title":"Mirror readmission study of the association of electroconvulsive therapy with 1-year mood disorder readmissions in a tertiary mood disorder unit.","volume":"36","author":"Tor","year":"2020","journal-title":"J ECT"},{"key":"yoi240052r13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/NDT.S415878","article-title":"Effect of continuation-maintenance electroconvulsive therapy on hospitalization: a retrospective mirror-image study.","volume":"19","author":"Sombatcharoen-Non","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"yoi240052r14","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000983","article-title":"Long-term effect of maintenance electroconvulsive therapy in patients with depression-data from a small randomized controlled trial.","author":"Brus","year":"2024","journal-title":"J ECT"},{"key":"yoi240052r15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jad.2023.06.016","article-title":"The association between outpatient continuation\/maintenance electroconvulsive therapy, readmission risk and total direct cost in patients with depressive, bipolar and psychotic disorders: a naturalistic retrospective cohort study.","volume":"338","author":"Koh","year":"2023","journal-title":"J Affect Disord"},{"issue":"4","key":"yoi240052r16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/YCT.0000000000000381","article-title":"Time trends and variations in electroconvulsive treatment in Denmark 2008 to 2014: a nationwide register-based study.","volume":"33","author":"Hundrup","year":"2017","journal-title":"J ECT"},{"issue":"4","key":"yoi240052r17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/YCT.0b013e3182107405","article-title":"Continuation and maintenance electroconvulsive therapy.","volume":"27","author":"Fox","year":"2011","journal-title":"J ECT"},{"issue":"3","key":"yoi240052r18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","article-title":"Data resource profile: the Danish National Prescription Registry.","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"11","key":"yoi240052r19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009120","article-title":"Are suicide deaths under-reported? nationwide re-evaluations of 1800 deaths in Scandinavia.","volume":"5","author":"T\u00f8llefsen","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"yoi240052r20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/08039480510027706","article-title":"Registration, psychiatric evaluation and adherence to psychiatric treatment after suicide attempt.","volume":"59","author":"Nordentoft","year":"2005","journal-title":"Nord J Psychiatry"},{"issue":"6","key":"yoi240052r23","first-page":"1","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: an economic analysis.","volume":"16","author":"Health Quality Ontario","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"issue":"7","key":"yoi240052r24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jamapsychiatry.2018.0768","article-title":"Cost-effectiveness of electroconvulsive therapy vs pharmacotherapy\/psychotherapy for treatment-resistant depression in the United States.","volume":"75","author":"Ross","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"yoi240052r25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00127-022-02243-9","article-title":"Treatment-resistant depression and labor market affiliation in the Danish welfare society: a register-based study.","volume":"57","author":"Gronemann","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"7","key":"yoi240052r26","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"issue":"15","key":"yoi240052r27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score.","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"yoi240052r28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/joim.12186","article-title":"Use of self-controlled designs in pharmacoepidemiology.","volume":"275","author":"Hallas","year":"2014","journal-title":"J Intern Med"},{"key":"yoi240052r29","doi-asserted-by":"publisher","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs.","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"yoi240052r30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/acps.13373","article-title":"Electroconvulsive therapy and psychiatric readmission in major depressive disorder: a population-based register study.","volume":"144","author":"Stenmark","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"yoi240052r31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.","volume":"172","author":"Petrides","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi240052r32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/YCT.0000000000000588","article-title":"Continuation electroconvulsive therapy for patients with clozapine-resistant schizophrenia: a pilot study.","volume":"35","author":"Braga","year":"2019","journal-title":"J ECT"},{"issue":"1","key":"yoi240052r33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/YCT.0000000000000613","article-title":"Clinical effectiveness of maintenance electroconvulsive therapy in patients with schizophrenia: a retrospective cohort study.","volume":"36","author":"Isserles","year":"2020","journal-title":"J ECT"},{"issue":"4","key":"yoi240052r34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/schbul\/sbac027","article-title":"Comparison of acute followed by maintenance ECT vs clozapine on psychopathology and regional cerebral blood flow in treatment-resistant schizophrenia: a randomized controlled trial.","volume":"48","author":"Mishra","year":"2022","journal-title":"Schizophr Bull"},{"issue":"3","key":"yoi240052r35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1192\/bjp.bp.114.158261","article-title":"Evaluation of cumulative cognitive deficits from electroconvulsive therapy.","volume":"208","author":"Kirov","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"3","key":"yoi240052r36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/acps.13314","article-title":"Effectiveness of maintenance electroconvulsive therapy: evidence from modifications due to the COVID-19 pandemic.","volume":"144","author":"Methfessel","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"yoi240052r37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/YCT.0000000000000785","article-title":"Discontinuation of continuation or maintenance electroconvulsive therapy caused by the COVID-19 pandemic: a naturalistic study investigating relapse in patients with major depressive disorder.","volume":"37","author":"Van de Velde","year":"2021","journal-title":"J ECT"},{"key":"yoi240052r21","unstructured":"Sundhedsdatastyrelsen. Takstsystem 2024. Published 2023. Accessed August 16, 2024. https:\/\/sundhedsdatastyrelsen.dk\/-\/media\/sds\/filer\/finansiering-og-afregning\/takster\/2024\/takstvejledning_2024.pdf"},{"key":"yoi240052r22","unstructured":"Medicinr\u00e5det. Esketamin som korttidsbehandling til patienter med depression. Published 2023. Accessed August 16, 2024. https:\/\/medicinraadet.dk\/media\/psvjpzwz\/bilag-til-medicinr\u00e5dets-anbefaling-vedr-esketamin-til-depression-som-akut-kortidsbehandling-vers-1-0.pdf"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2823669\/jamapsychiatry_jrgensen_2024_oi_240052_1783372164.56262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:00:46Z","timestamp":1783522846000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2823669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.2360","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}